Archived Insight | August 18, 2020

Endowment Strategies for Higher Education

Higher education is in a financial crisis due to COVID-19. Revenue is down, the fall semester is uncertain and the markets have negatively affected many endowments.

Our nationally recognized investment experts from Segal Marco Advisors share essential insights every institutional investor, CFO, board member and school leader should know about endowment investing during these trying times.

Among other things, they address:

  • Asset allocation and spending rate analysis
  • Prioritizing near term cash and cash flow needs
  • Agile investment policy
  • Manager selection
  • Opportunities for yield and liquidity in an ongoing COVID-19 environment
Endowment Strategies for Higher Education

Explore all COVID-19 information

We're regularly publishing more information on the coronavirus as the situation develops.

Learn More

Learn more from our insights

Male Therapist Encourages Distressed Male Veteran

MHPAEA Litigation and Enforcement News

See the Mental Health Parity and Addiction Equity Act (MHPAEA) litigation on hold and enforcement considerations, plus next steps for plan sponsors.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Architecture Engineering & Construction, Higher Education, Mental Health

Read Full Insight

Businesswoman Reviewing Finance Charts In The Office

Model Pension Plan's Funded Status Decreases by 3 Points

In Q1 2025, the funded status of our model private sector single-employer pension plan fell 3 points to 107%. Learn why in the latest Prism.

Retirement, Investment, Corporate

Read Full Insight

Overweight Black Woman Talking To Doctor In Medical Clinic

Survey of How Plans Are Covering GLP-1s: for Weight Loss or Diabetes Only

Are health plans covering GLP-1s for weight loss or for diabetes only? The answers from the 160 large group health plans we surveyed may surprise you.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate, Pharmaceutical

Get the Infographic

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.